Alantra acts as Joint Bookrunner on a landmark accelerated bookbuild for Izertis

Jan 2026

Accelerated Bookbuilding

Value €54mn

Madrid – Alantra acted as Joint Bookrunner on a landmark accelerated bookbuild of primary shares (capital increase) for Izertis. The transaction comprised a €51.3mn capital increase and the sale of €2.8mn of treasury shares, resulting in a total transaction size of approximately €54mn, representing 20.26% of the Company’s share capital.

The transaction marks a significant milestone for Izertis as a listed company and is expected to provide renewed momentum to its equity story. The capital increase will enable Izertis to accelerate its growth plan, both organically and through selective inorganic opportunities, reinforcing its positioning in the public markets.

Alantra played a key role in the execution of the transaction, including the origination of two cornerstone investors and the placement with continental European small-cap investors, with the support of Alantra’s office in Italy.

André Pereira-Ambrosio, Partner and Head of ECM Iberia, said: “This transaction is the result of extensive work and commitment by the team at Izertis. It was an honor for Alantra to support the Company on such an important milestone. The evolution of Izertis represents a clear case study for Spanish capital markets, and this transaction once again highlights the relevance of our pan-European reach.”

This transaction further highlights Alantra’s solid execution capabilities and track record in equity capital markets, building on recent mandates such as acting as Global Coordinator in the c.€42.4mn placement of Clínica Baviera’s shares and as Joint Bookrunner in Neinor Homes’ most recent €140mn capital increase, reinforcing the firm’s position within the Iberian market.